Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial
Lancet (in press)
DOI 10.1016/S0140-6736(24)00317-9, PubMed 38521086
Corrigendum to "Self-reported lower extremity lymphedema and quality of life after surgical staging of endometrial carcinoma: A population based cross-sectional study" [Gynecologic Oncology 175 (2023) 72-80]
Gynecol Oncol, 183, 7-8 (in press)
DOI 10.1016/j.ygyno.2024.02.026, PubMed 38484693
Surgery for gynecological cancers in the era of personalized medicine: a novel paradigm
Int J Gynecol Cancer, 34 (3), 351
DOI 10.1136/ijgc-2024-005299, PubMed 38438173